These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6812543)

  • 21. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
    Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection.
    Thomas LD; Cripps AW; Kyd JM
    Vaccine; 2009 May; 27(25-26):3324-30. PubMed ID: 19200832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
    Onlen Y; Tamer C; Oksuz H; Duran N; Altug ME; Yakan S
    Microbiol Res; 2007; 162(1):62-8. PubMed ID: 16904302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
    Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal response to Pseudomonas aeruginosa infection.
    Hazlett LD
    Prog Retin Eye Res; 2004 Jan; 23(1):1-30. PubMed ID: 14766315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of purified proteases (I-elastase, II-protease) on the course of Pseudomonas aeruginosa infection in DBA/2H mice].
    Pajdak E; Stankiewicz D
    Med Dosw Mikrobiol; 1982; 34(3-4):139-43. PubMed ID: 6820452
    [No Abstract]   [Full Text] [Related]  

  • 29. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
    Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
    FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vivo effects of Pseudomonas aeruginosa proteases on human plasma proteins].
    Müller HE
    Dtsch Med Wochenschr; 1971 Jul; 96(31):1278-82. PubMed ID: 4997689
    [No Abstract]   [Full Text] [Related]  

  • 31. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
    Meitert T; Meitert E; Szegli G; Peligrad I
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
    [No Abstract]   [Full Text] [Related]  

  • 33. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review.
    Willcox MD
    Optom Vis Sci; 2007 Apr; 84(4):273-8. PubMed ID: 17435510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine strategies against Pseudomonas aeruginosa infection in the lung.
    Cripps AW; Dunkley ML; Clancy RL; Kyd J
    Behring Inst Mitt; 1997 Feb; (98):262-8. PubMed ID: 9382749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical immunotherapy for pseudomonas keratitis in rabbits: use of antilipopolysaccharide plasma.
    Welsh NH; Rauch AJ; Gaffin SL
    Br J Ophthalmol; 1984 Nov; 68(11):828-32. PubMed ID: 6437435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On pseudomonas aerugenosa immunity to microwave energies].
    Klimarev SI; Kanatova GV
    Aviakosm Ekolog Med; 2009; 43(6):28-30. PubMed ID: 20169736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Water chlorination controls Pseudomonas aeruginosa in a rabbitry.
    McDonald RA; Pinheiro AF
    J Am Vet Med Assoc; 1967 Oct; 151(7):863-4. PubMed ID: 4964825
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between proteases and descemetocele formation in experimental Pseudomonas keratitis.
    Twining SS; Davis SD; Hyndiuk RA
    Curr Eye Res; 1986 Jul; 5(7):503-10. PubMed ID: 3527568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.